Clinical Trial Update: GEP Combined With Radiotherapy in Non-locally Treatable Recurrent NPC [Phase 2]

View source ↗

Summary

A phase 2 clinical trial evaluating GEP combined with radiotherapy for non-locally treatable recurrent nasopharyngeal carcinoma; the study is not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• GEP

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Nasopharynx Cancer | Phase 2 | Status: NOT_YET_RECRUITING